Qube Research & Technologies (QRT)
PCRX icon

Qube Research & Technologies (QRT)’s Pacira BioSciences PCRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,307
Closed -$420K – 3974
2025
Q3 		$420K Buy
+16,307
New +$401K ﹤0.01% 2759
2025
Q1 		– Sell
-84,039
Closed -$1.58M – 3783
2024
Q4 		$1.58M Sell
84,039
-276,166
-77% -$4.85M ﹤0.01% 1976
2024
Q3 		$5.42M Buy
360,205
+231,014
+179% +$3.95M 0.01% 1349
2024
Q2 		$3.7M Buy
+129,191
New +$3.68M 0.01% 1399
2023
Q4 		– Sell
-17,807
Closed -$546K – 4639
2023
Q3 		$546K Buy
+17,807
New +$642K ﹤0.01% 1993
2023
Q2 		– Sell
-37,010
Closed -$1.51M – 2844
2023
Q1 		$1.51M Sell
37,010
-15,694
-30% -$624K 0.01% 1129
2022
Q4 		$2.03M Buy
+52,704
New +$2.56M 0.01% 944
2022
Q3 		– Sell
-23,754
Closed -$1.39M – 2876
2022
Q2 		$1.39M Buy
+23,754
New +$1.56M 0.01% 973
2022
Q1 		– Sell
-7,798
Closed -$469K – 2856
2021
Q4 		$469K Sell
7,798
-768
-9% -$42.3K ﹤0.01% 1605
2021
Q3 		$480K Sell
8,566
-32
-0.4% -$1.84K 0.01% 1231
2021
Q2 		$522K Buy
8,598
+3,852
+81% +$244K 0.01% 1269
2021
Q1 		$333K Buy
+4,746
New +$339K 0.01% 1405
2020
Q3 		– Sell
-14,329
Closed -$752K – 2007
2020
Q2 		$752K Buy
+14,329
New +$599K 0.01% 962
2020
Q1 		– Sell
-13,402
Closed -$607K – 1515
2019
Q4 		$607K Buy
+13,402
New +$569K 0.02% 858

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PCRX Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 16,307 shares — an estimated $420K sold.

Qube Research & Technologies (QRT) first reported a position in PCRX in Q4 2019 and held it in 14 quarters. The position peaked at $5.42M in Q3 2024. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 16,307 Pacira BioSciences shares in Q4 2025, an estimated $420K.
  • Qube Research & Technologies (QRT) first reported a position in Pacira BioSciences in Q4 2019 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s Pacira BioSciences position peaked at $5.42M in Q3 2024.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.